The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
A Review and Update on Cholangiocarcinoma
Abstract
Cholangiocarcinoma is a malignant neoplasm arising from the biliary epithelium that was first described by Durand-Fardel in 1840. Today, it continues to defy diagnosis and treatment. It is difficult to diagnose in part because of its relative rarity, and because it is clinically silent until it becomes advanced disease with obstructive symptoms. The worldwide incidence of cholangiocarcinoma has risen over the past three decades. There is marked geographic variability in the prevalence of this disease, due in large part to regional environmental risk factors. Surgical resection remains the only curative treatment, and high priorities are improving diagnostic methods, and clinical staging for resection once the disease is suspected. A recent trend towards aggressive surgical management has improved outcomes. Chemotherapy, palliative stenting, and radiation are reserved for patients who are not resectable, those with recurrence after surgery, and those who decline surgical intervention. Recent trials using combination systemic chemotherapy and neoadjuvant chemoradiation are promising, but require further study. Over the past five years, several important studies have yielded new insights into the molecular mechanisms of cholangiocarcinoma tumorigenesis. In this review we discuss epidemiology, etiologic factors, molecular pathogenesis, diagnosis, staging, and treatment of cholangiocarcinoma. Particular focus is on recent studies into the cellular and molecular pathogenesis of the disease, recent chemotherapy trials, and newer methods of staging and screening for this devastating malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Endosonography-guided fine-needle aspiration biopsy: Diagnostic accuracy and complication assessment
Wiersema, M., Vilmann, P., Giovannini, M., Chang, K., & Wiersema, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70164-1 · Cited by 1,131
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis
Klatskin, G. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90178-6 · Cited by 820
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
Bismuth, H., & Corlette, M. B. (1975) · PubMed · Cited by 751
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Khan, S. A., Davidson, B. R., Goldin, R., Pereira, S. P., Rosenberg, W. M. C., Taylor-Robinson, S. D., Thillainayagam, A. V., Thomas, H. C., Thursz, M. R., & Wasan, H. (2002) · Gut · doi:10.1136/gut.51.suppl_6.vi1 · Cited by 648
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Health Effects of Dioxin Exposure: A 20-Year Mortality Study
Bertazzi, P. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.11.1031 · Cited by 504
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Meyer, C. G., Penn, I., & James, L. (2000) · Transplantation · doi:10.1097/00007890-200004270-00019 · Cited by 502
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Burke, E. C., Jarnagin, W. R., Hochwald, S. N., Pisters, P. W. T., Fong, Y., & Blumgart, L. H. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00011 · Cited by 468
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
De Vreede, I., Steers, J. L., Burch, P. A., Rosen, C. B., Gunderson, L. L., Haddock, M. G., Burgart, L., & Gores, G. J. (2000) · Liver Transplantation · doi:10.1053/lv.2000.6143 · Cited by 395
Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis
ROSEN, C. B., NAGORNEY, D. M., WIESNER, R. H., COFFEY, R. J., & LARUSSO, N. F. (1991) · Annals of Surgery · doi:10.1097/00000658-199101000-00004 · Cited by 391
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Kosuge, T., Yamamoto, J., Shimada, K., Yamasaki, S., & Makuuchi, M. (1999) · Annals of Surgery · doi:10.1097/00000658-199911000-00008 · Cited by 337
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Total antioxidant potential of fruit and vegetables and risk of gastric cancer
Serafini, M., Bellocco, R., Wolk, A., & Ekström, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.35957 · Cited by 321
Sudan, D., DeRoover, A., Chinnakotla, S., Fox, I., Shaw, B., McCashland, T., Sorrell, M., Tempero, M., & Langnas, A. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20812.x · Cited by 314
Liver fluke-associated cholangiocarcinoma
Watanapa, P., & Watanapa, W. B. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02143.x · Cited by 303
Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival
Pitt, H. A., Nakeeb, A., Abrams, R. A., Coleman, J., Piantadosi, S., Yeo, C. J., Lillemoe, K. D., & Cameron, J. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00017 · Cited by 299
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
Ramage, J. K., Donaghy, A., Farrant, J. M., Iorns, R., & Williams, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90462-x · Cited by 279
Photodynamic therapy of nonresectable cholangiocarcinoma
Ortner, M. E. J., Liebetruth, J., Schreiber, S., Hanft, M., Wruck, U., Fusco, V., Müller, J. M., Hörtnagl, H., & Lochs, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70537-2 · Cited by 269
Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F. (2001) · Hepatology · doi:10.1053/jhep.2001.23912 · Cited by 265
Risk factors for biliary tract carcinogenesis
Chapman, R. W. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s308 · Cited by 244
Nakamura, T., Sakata, R., Ueno, T., Sata, M., & Ueno, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9109 · Cited by 242
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
McMasters, K. M., Tuttle, T. M., Leach, S. D., Rich, T., Cleary, K. R., Evans, D. B., & Curley, S. A. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00203-1 · Cited by 220
Teefey, S. A., Hildeboldt, C. C., Dehdashti, F., Siegel, B. A., Peters, M. G., Heiken, J. P., Brown, J. J., McFarland, E. G., Middleton, W. D., Balfe, D. M., et al. (2003) · Radiology · doi:10.1148/radiol.2262011980 · Cited by 214
What constitutes long term survival after surgery for hilar cholangiocarcinoma?
Klempnauer, J., Ridder, G. J., Werner, M., Weimann, A., & Pichlmayr, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970101)79:1<26::aid-cncr5>3.0.co;2-k · Cited by 197
Aggressive Surgical Resection for Cholangiocarcinoma
Washburn, W. K. (1995) · Archives of Surgery · doi:10.1001/archsurg.1995.01430030040006 · Cited by 194
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Endo, K., Yoon, B.-I., Pairojkul, C., Demetris, A. J., & Sirica, A. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34435 · Cited by 188
Benckert, C., Jonas, S., Cramer, T., von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., et al. (2003) · PubMed · Cited by 185
Improved survival in resected biliary malignancies
Nakeeb, A., Tran, K. Q., Black, M. J., Erickson, B. A., Ritch, P. S., Quebbeman, E. J., Wilson, S. D., Demeure, M. J., Rilling, W. S., Dua, K. S., et al. (2002) · Surgery · doi:10.1067/msy.2002.127555 · Cited by 177
Hepatolithiasis associated with cholangiocarcinoma
Kubo, S., Kinoshita, H., Hirohashi, K., & Hamda, H. (1995) · World Journal of Surgery · doi:10.1007/bf00294744 · Cited by 177
Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., & Nakamura, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202231 · Cited by 176
Malignancies of the biliary tree
Pitt, H. A., Yeo, C. J., Dooley, W. C., & Cameron, J. L. (1995) · Current Problems in Surgery · doi:10.1016/s0011-3840(05)80011-5 · Cited by 171
Mortality of Workers Exposed to Polychlorinated Biphenyls—An Update
Brown, D. P. (1987) · Archives of Environmental Health: An International Journal · doi:10.1080/00039896.1987.9934355 · Cited by 165
COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells
Nzeako, U. C., Guicciardi, M. E., Yoon, J.-H., Bronk, S. F., & Gores, G. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31774 · Cited by 163
Kubicka, S., Rudolph, K. L., Tietze, M. K., et al. (2002) · PubMed · Cited by 147
Aberrant CpG Island Methylation of Multiple Genes in Intrahepatic Cholangiocarcinoma
Lee, S., Kim, W. H., Jung, H., Yang, M. H., & Kang, G. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64262-9 · Cited by 143
Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90650-9 · Cited by 135
Hepatolithiasis associated with cholangiocarcinoma
Su, C.-H., Ym, S., Lui, W., et al. (1997) · British journal of surgery · doi:10.1002/bjs.1800840717 · Cited by 124
Cholangiocarcinoma of the extrahepatic bile ducts
Jarnagin, W. R. (2000) · Seminars in Surgical Oncology · Cited by 120
Aishima, S., Taguchi, K., Sugimachi, K., Shimada, M., Sugimachi, K., & Tsuneyoshi, M. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.00353.x · Cited by 119
Early detection and treatment of cholangiocarcinoma
Gores, G. J. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.18688 · Cited by 116
Kang, Y. K., Kim, W. H., & Jang, J. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.127444 · Cited by 116
Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma
Sugimachi, K., Taguchi, K., Aishima, S., Tanaka, S., Shimada, M., Kajiyama, K., Sugimachi, K., & Tsuneyoshi, M. (2001) · Modern Pathology · doi:10.1038/modpathol.3880409 · Cited by 114
Farrell, R. J., Agarwal, B., Brandwein, S. L., Underhill, J., Chuttani, R., & Pleskow, D. K. (2002) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(02)70117-x · Cited by 108
Isa, T., Tomita, S., Nakachi, A., Miyazato, H., Shimoji, H., Kusano, T., Muto, Y., & Furukawa, M. (2002) · PubMed · Cited by 104
Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis
Fleming, K. A., Boberg, K. M., Glaumann, H., Bergquist, A. M., Smith, D., & Clausen, O. P. F. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00034-9 · Cited by 100
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 99
The German Thorotrast Study: Recent Results and Assessment of Risks
KAICK, G. V., Dalheimer, A., Hornik, S., Kaul, A., Liebermann, D., Lührs, H., Spiethoff, A., Wegener, K., Wesch, H., & Luhrs, H. (1999) · Radiation Research · doi:10.2307/3580117 · Cited by 99
Liver Cancers in Mayak Workers
Gilbert, E. S., Koshurnikova, N. A., Эдуардович, С. М., Khokhryakov, V. F., Miller, S. C., Preston, D. L., Romanov, S. A., Shilnikova, N. S., Suslova, K. G., & Vostrotin, V. V. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)154[0246:lcimw]2.0.co;2 · Cited by 89
Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma
Chariyalertsak, S., Sirikulchayanonta, V., Mayer, D., Kopp‐Schneider, A., Fürstenberger, G., Marks, F., & Müller-Decker, K. (2001) · Gut · doi:10.1136/gut.48.1.80 · Cited by 84
Ahn, E.-Y. E., Pan, G., Vickers, S. M., & McDonald, J. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10516 · Cited by 83
Okaro, A. C., Deery, A., Hutchins, R., & Davidson, B. R. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.12.927 · Cited by 77
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma
Wong, N., Li, L., Tsang, K. S., Lai, P. B. S., To, K., & Johnson, P. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00269-6 · Cited by 68
Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
Kim, Y.-T., Byun, J. S., Kim, M. J., Jang, Y. H., Lee, W. J., Ryu, J.-G., Kim, S. W., Yb, Y., & Kim, C. Y. (2003) · PubMed · Cited by 64
Kaya, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02259-6 · Cited by 64
Asbestos bodies in a bile duct cancer after occupational exposure
Szendröi, M., Németh, L., & Vajta, G. (1983) · Environmental Research · doi:10.1016/0013-9351(83)90213-x · Cited by 52
Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection
Satarug, S., Haswell, M., Tsuda, M., Mairiang, P., Sithithaworn, P., Mairiang, E., Esumi, H., Sukprasert, S., Yongvanit, P., & Elkins, D. B. (1996) · Carcinogenesis · doi:10.1093/carcin/17.5.1075 · Cited by 48
Limpaiboon, T., Krissadarak, K., Sripa, B., Jearanaikoon, P., Bhuhisawasdi, V., Chau‐in, S., Romphruk, A. V., & Pairojkul, C. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00052-6 · Cited by 34
Photodynamic therapy for cholangiocarcinoma
Ortner, M. (2001) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340170036 · Cited by 33
Prevention of bile duct cancer in primary sclerosing cholangitis
Harrison, P. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s208 · Cited by 26
ets-1 Expression in Extrahepatic Bile Duct Carcinoma and Cholangiocellular Carcinoma
Ito, Y., Miyoshi, E., Takeda, T., Sakon, M., Tsujimoto, M., Yokosaki, Y., Monden, M., & Matsuura∥, N. (2000) · Oncology · doi:10.1159/000012108 · Cited by 23
Cited by
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Liver Fluke Induces Cholangiocarcinoma
Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040201 · Cited by 775
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
Shin, H., Oh, J., Masuyer, E., Curado, M., Bouvard, V., Fang, Y., Wiangnon, S., Sripa, B., & Hong, S. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01458.x · Cited by 454
Ringe, K. I., Husarik, D. B., Sirlin, C. B., & Merkle, E. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4392 · Cited by 388
Metadata
- Authors
- Olnes, M. J., & Erlich, R.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 66
- Issue
- 3
- Pages
- 167-179
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W1993180801
- Cited by
- 266
- References
- 70
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.